Co-Authors
This is a "connection" page, showing publications co-authored by SUSAN K PETERSON and ROBERT VOLK.
Connection Strength
1.226
-
A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. Cancer Med. 2023 02; 12(3):2875-2884.
Score: 0.216
-
Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes. Cancer. 2021 10 01; 127(19):3605-3613.
Score: 0.196
-
Disclosure of familial implications of pathogenic variants in breast-cancer genes to patients: Opportunity for prompting family communication. J Community Genet. 2021 Jul; 12(3):439-447.
Score: 0.190
-
Perceptions of provider's epistemic authority in response to variant of uncertain significance-related recommendations. J Genet Couns. 2020 Oct 08.
Score: 0.186
-
What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responses. Cancer. 2024 Nov 15; 130(22):3926-3934.
Score: 0.060
-
Financial toxicity in cancer patients and subsequent risk of repeat acute care utilization. Front Psychol. 2023; 14:1209526.
Score: 0.057
-
Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency. Front Psychol. 2023; 14:1188783.
Score: 0.056
-
Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One. 2022; 17(8):e0272804.
Score: 0.053
-
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer. 2022 07 01; 128(13):2455-2462.
Score: 0.052
-
Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery. JCO Oncol Pract. 2021 12; 17(12):e1856-e1865.
Score: 0.049
-
Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol. 2018 09 01; 36(25):2630-2638.
Score: 0.040
-
Assessing head and neck cancer patient preferences and expectations: A systematic review. Oral Oncol. 2016 11; 62:44-53.
Score: 0.035
-
Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). Breast Cancer Res. 2016 09 20; 18(1):93.
Score: 0.035